Bayview Pharmacy is pleased to present a specially compounded oral suspension formulation of Montelukast 1 mg/ml, Ketotifen 0.5 mg/ml, and Budesonide 0.5 mg/ml. This unique combination of medications is designed to address a range of conditions such as asthma, allergic rhinitis, and chronic urticaria.

Montelukast is an anti-inflammatory medication that operates by inhibiting the action of leukotrienes, chemicals that trigger inflammation in the airways. Ketotifen, an antihistamine, functions by blocking the action of histamine, a chemical that induces inflammation in the body. Budesonide, a corticosteroid, works by reducing inflammation in the airways. Together, these medications form a potent treatment for asthma, allergic rhinitis, and chronic urticaria.

This formulation is a liquid dosage form in which the active ingredients are uniformly dispersed throughout a liquid medium, creating a homogeneous mixture for administration. This ensures that each dose contains the exact amount of each medication, providing consistent and effective treatment. The liquid form also makes it easy to adjust the dose to meet individual patient needs.

By reducing inflammation in the airways, this combination of medications can help alleviate the severity of symptoms and enhance overall quality of life. The formulation is easy to administer and can be taken with or without food, offering flexibility and convenience for patients.

If you have any queries about this formulation or how it can assist in managing your condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most suitable treatment option for your specific needs.

Montelukast 1 mg/ml/Ketotifen 0.5 mg/ml/Budesonide 0.5 mg/ml Oral Suspension is a compounded formulation designed for the treatment of asthma, allergic rhinitis, and chronic idiopathic urticaria. This liquid dosage form ensures a uniform dispersion of the active ingredients, providing a homogeneous mixture for administration.

The formulation combines three active ingredients: Montelukast, Ketotifen, and Budesonide. Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, substances that cause inflammation in the airways. Ketotifen is an antihistamine that inhibits the action of histamine, another substance that triggers inflammation in the airways. Budesonide is a corticosteroid that reduces inflammation in the airways. Together, these medications work synergistically to reduce inflammation and alleviate symptoms associated with asthma, allergic rhinitis, and chronic idiopathic urticaria.

It is crucial for patients to be aware that this formulation may interact with other medications, including other corticosteroids, antifungals, and antibiotics. Therefore, it is recommended that patients inform their healthcare provider of all medications they are currently taking before starting this formulation. Potential side effects of this medication may include nausea, vomiting, headache, and dizziness.

If you have any questions or concerns about Montelukast 1 mg/ml/Ketotifen 0.5 mg/ml/Budesonide 0.5 mg/ml Oral Suspension or its potential interactions with other medications, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.

Montelukast 1 mg/ml/Ketotifen 0.5 mg/ml/Budesonide 0.5 mg/ml Oral Suspension is a compounded formulation designed to manage and treat conditions such as asthma, allergic rhinitis, and chronic idiopathic urticaria. This medication combines the therapeutic benefits of three active ingredients: Montelukast, Ketotifen, and Budesonide.

Montelukast is a leukotriene receptor antagonist. It functions by obstructing the action of leukotrienes, substances in the body that trigger inflammation. This action helps to reduce swelling and inflammation in the airways, making breathing easier.

Ketotifen is an antihistamine. It works by blocking the action of histamine, a substance in the body that triggers allergic symptoms. By inhibiting histamine, Ketotifen helps to alleviate symptoms such as sneezing, itching, watery eyes, and runny nose associated with allergic reactions.

Budesonide is a corticosteroid. It operates by reducing inflammation in the airways, further aiding in the relief of breathing difficulties. This ingredient is particularly beneficial for individuals with asthma and other respiratory conditions.

This combination medication is administered orally, typically once a day. It is crucial to follow the prescribed dosage from your healthcare provider. Do not alter the dosage without consulting your doctor. The full benefits of this medication may take several weeks to manifest, so it's important to continue taking it even if immediate improvements are not noticed.

If you have any queries or concerns about this medication, do not hesitate to seek professional advice. Understanding how this medication works and how it can assist in managing your condition is crucial for effective treatment.

This compounded formulation of Montelukast 1 mg/ml, Ketotifen 0.5 mg/ml, and Budesonide 0.5 mg/ml is presented as an Oral Suspension. It is a liquid dosage form where the active ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration. This formulation is primarily used in the treatment of various respiratory conditions such as asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD), bronchopulmonary dysplasia, and eosinophilic esophagitis. It may also be prescribed for other conditions as determined by your healthcare provider.

It is important to note that this formulation is not recommended for use in children under the age of 6 years. Patients using this medication should be closely monitored for signs and symptoms of infection, which may include fever, cough, and shortness of breath. Additionally, signs and symptoms of adrenal insufficiency such as fatigue, weakness, nausea, and vomiting should also be closely monitored.

Patients are advised to avoid contact with individuals who have recently received live vaccines to prevent potential complications. If you have any questions or concerns regarding the use of this formulation, please consult with your healthcare provider for further guidance.